This Article Full Text Full Text (PDF) All Versions of this Article: 50/6/1142    most recent HYPERTENSIONAHA.107.096594v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gilbert, J. S. Articles by Granger, J. P. Search for Related Content PubMed PubMed Citation Articles by Gilbert, J. S. Articles by Granger, J. P. Related Collections Animal models of human disease Other hypertension Hypertension - basic studies

(Hypertension. 2007;50:1142.)
© 2007 American Heart Association, Inc.

Original Articles

Hypertension Produced by Reduced Uterine Perfusion in Pregnant Rats Is Associated With Increased Soluble Fms-Like Tyrosine Kinase-1 Expression

From the Department of Physiology and the Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, Miss.

Correspondence to Joey P. Granger, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 N State St, Jackson, MS 39216-4505. E-mail jgranger{at}physiology.umsmed.edu

The balance between proangiogenic and antiangiogenic factors, such as vascular endothelial growth factor, placental growth factor, and soluble fms-like tyrosine kinase-1 (sFlt-1), is altered in preeclampsia, and this dysregulation of angiogenic factors may be important in the pathogenesis of preeclampsia. Although sFlt-1 is elevated in preeclampsia, the mechanisms responsible for increasing this antiangiogenic factor remain unclear. We hypothesized that the hypertension produced by reduced uterine perfusion pressure (RUPP) is associated with increased sFlt-1 expression and decreased plasma vascular endothelial growth factor and placental growth factor concentrations in the pregnant rat. Arterial pressure was increased (130±3 versus 100±2 mm Hg; P<0.01) in the RUPP rats compared with the normal pregnant control rats. Plasma sFlt-1 concentration (660±270 versus 82±26 pg/mL; P<0.05) was increased, whereas plasma free placental growth factor (0.28±0.05 versus 1.7±0.5 pg/mL; P<0.01) and vascular endothelial growth factor (594±34 versus 830±33 pg/mL; P<0.01) concentrations were decreased in the RUPP rats compared with normal pregnant rats. Plasma sFlt-1:placental growth factor (37.2±7.8 versus 8.9±1.6; P<0.02) and sFlt-1:vascular endothelial growth factor (0.86±0.22 versus 0.28±0.06; P<0.05) ratios were increased in the RUPP rats compared with normal pregnant rats. Immunoreactive placental sFlt-1 was increased (1.1±0.1 versus 0.3±0.1; P<0.01) in RUPP rats contrasted with the normal pregnant rats. These findings support our hypothesis that RUPP increases the expression of sFlt-1 and alters the balance of angiogenic factors in the maternal circulation. These data also indicate that the RUPP model of pregnancy-induced hypertension may provide an invaluable model for mechanistic studies into the role of sFlt-1 in the pathogenesis preeclampsia.

Key Words: preeclampsia • gestation • VEGF • blood pressure • angiogenic

This article has been cited by other articles:

				S. Verlohren, D. N. Muller, F. C. Luft, and R. Dechend Immunology in Hypertension, Preeclampsia, and Target-Organ Damage Hypertension, September 1, 2009; 54(3): 439 - 443. [Full Text] [PDF]

				S. K. Walsh, F. A. English, E. J. Johns, and L. C. Kenny Plasma-Mediated Vascular Dysfunction in the Reduced Uterine Perfusion Pressure Model of Preeclampsia: A Microvascular Characterization Hypertension, August 1, 2009; 54(2): 345 - 351. [Abstract] [Full Text] [PDF]

				C. P. Thomas, J. I. Andrews, N. S. Raikwar, E. A. Kelley, F. Herse, R. Dechend, T. G. Golos, and K. Z. Liu A Recently Evolved Novel Trophoblast-Enriched Secreted Form of fms-Like Tyrosine Kinase-1 Variant Is Up-Regulated in Hypoxia and Preeclampsia J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2524 - 2530. [Abstract] [Full Text] [PDF]

				J. S. Gilbert, S. A.B. Gilbert, M. Arany, and J. P. Granger Hypertension Produced by Placental Ischemia in Pregnant Rats Is Associated With Increased Soluble Endoglin Expression Hypertension, February 1, 2009; 53(2): 399 - 403. [Abstract] [Full Text] [PDF]

				S. E. Maynard and R. Thadhani Pregnancy and the Kidney J. Am. Soc. Nephrol., January 1, 2009; 20(1): 14 - 22. [Abstract] [Full Text] [PDF]

				J. S. Gilbert and M. J. Nijland Sex differences in the developmental origins of hypertension and cardiorenal disease Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1941 - R1952. [Abstract] [Full Text] [PDF]

				B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF]

				G. Osol, G. Celia, N. Gokina, C. Barron, E. Chien, M. Mandala, L. Luksha, and K. Kublickiene Placental growth factor is a potent vasodilator of rat and human resistance arteries Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1381 - H1387. [Abstract] [Full Text] [PDF]

				J. S. Gilbert, M. J. Ryan, B. B. LaMarca, M. Sedeek, S. R. Murphy, and J. P. Granger Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H541 - H550. [Abstract] [Full Text] [PDF]